Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Clinical trial NCT06424964 · RECRUITING

Trial details

NCT number: NCT06424964
Sponsor: Belgian Research on AIDS and HIV Consortium
Status: RECRUITING
Study type: OBSERVATIONAL

Human Immunodeficiency Virus

Start date: 2025-01-13
Primary completion: 2025-05-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.